New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Accolade, Inc.
ACCD
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

257M

Medical - Healthcare Information Services

Next Earning date - 13 Jan 2025

257M

Medical - Healthcare Information Services

Next Earning date - 13 Jan 2025

3.19USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

79%

Quote Panel

Shape
Updated October 26, 2024
1W -5.62 % 1M -17.36 % 3M -20.25 % 1Y -51.37 %

Key Metrics

Shape
  • Market Cap

    256.91M


  • Shares Outstanding

    80.54M


  • Share in Float

    69.12M


  • Dividende

    0


  • Earning Date

    13 Jan 2025


  • Price Target

    3.19


  • Average Volume

    1.18M


  • Beta

    1.993


  • Range

    3.13-15.36


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.accolade.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.58x

P/S Ratio

0.60x

P/B Ratio

0.5

Debt/Equity

-18.2%

Net Margin

$-1.0

EPS

How ACCD compares to sector?

P/E Ratio

Relative Strength

Shape

ACCD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$466M

Shape338%

2025-Revenue

$0.93

Shape-209%

2025-EPS

$55M

Shape-252%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Exane BNP Paribas

downgrade

Previous: Not converted

2023-05-24

Now: Underperform

Raymond James

initialise

Previous: Outperform

2023-05-24

Now: Market Perform

Barclays

upgrade

Previous: Not converted

2023-05-24

Now: Overweight

Bank of America Securities

upgrade

Previous: Neutral

2023-05-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.56
vs -0.39

Q1.23

arrow
arrow

N/A

-0.42
vs -0.27

Q2.23

arrow
arrow

N/A

-0.52
vs -0.40

Q3.23

arrow
arrow

N/A

-0.43
vs -0.66

Q4.23

arrow
arrow

N/A

-0.28
vs -0.56

Q1.24

arrow
arrow

N/A

-0.10
vs -0.42

Q2.24

arrow
arrow

N/A

-0.35
vs -0.52

Q3.24

arrow
arrow

N/A

-0.30
vs -0.43

Q4.24

arrow
arrow

N/A

-0.33
vs -0.28

Q1.25

arrow
arrow

+137%

0.04
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+9%

90.9M  vs 83.5M

Q1.23

arrow
arrow

+6%

99M  vs 93.8M

Q2.23

arrow
arrow

+9%

93.2M  vs 85.5M

Q3.23

arrow
arrow

+11%

96.9M  vs 87.6M

Q4.23

arrow
arrow

+9%

99.4M  vs 90.9M

Q1.24

arrow
arrow

+26%

124.8M  vs 99M

Q2.24

arrow
arrow

+18%

110.5M  vs 93.2M

Q3.24

arrow
arrow

+10%

106.4M  vs 96.9M

Q4.24

arrow
arrow

+7%

106M  vs 99.4M

Q1.25

arrow
arrow

+14%

142.4M  vs 124.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-8%

-0.08
vs -0.09

Q1.23

arrow
arrow

-6%

-0.06
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs -0.06

Q3.23

arrow
arrow

-8%

-0.08
vs -0.08

Q4.23

arrow
arrow

-5%

-0.05
vs -0.08

Q1.24

arrow
arrow

-2%

-0.02
vs -0.05

Q2.24

arrow
arrow

-6%

-0.06
vs -0.02

Q3.24

arrow
arrow

-6%

-0.06
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

161

161
vs 167

-4%

Q4.22

arrow
arrow

162

162
vs 161

1%

Q1.23

arrow
arrow

163

163
vs 162

1%

Q2.23

arrow
arrow

171

171
vs 163

5%

Q3.23

arrow
arrow

164

164
vs 171

-4%

Q4.23

arrow
arrow

151

151
vs 164

-8%

Q1.24

arrow
arrow

160

160
vs 151

6%

Q2.24

arrow
arrow

151

151
vs 160

-6%

Earnings Growth

Latest News